- Home
- ABVC vs RAND Comparison
ABVC vs RAND Comparison
Compare ABVC & RAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABVC
- RAND
- Stock Information
- Founded
- ABVC 2015
- RAND 1969
- Country
- ABVC United States
- RAND United States
- Employees
- ABVC N/A
- RAND N/A
- Industry
- ABVC Biotechnology: Pharmaceutical Preparations
- RAND Finance: Consumer Services
- Sector
- ABVC Health Care
- RAND Finance
- Exchange
- ABVC Nasdaq
- RAND Nasdaq
- Market Cap
- ABVC 52.1M
- RAND 54.4M
- IPO Year
- ABVC N/A
- RAND N/A
- Fundamental
- Price
- ABVC $3.30
- RAND $15.21
- Analyst Decision
- ABVC
- RAND
- Analyst Count
- ABVC 0
- RAND 0
- Target Price
- ABVC N/A
- RAND N/A
- AVG Volume (30 Days)
- ABVC 223.6K
- RAND 4.7K
- Earning Date
- ABVC 08-13-2025
- RAND 08-04-2025
- Dividend Yield
- ABVC N/A
- RAND 10.98%
- EPS Growth
- ABVC N/A
- RAND N/A
- EPS
- ABVC N/A
- RAND N/A
- Revenue
- ABVC $391,242.00
- RAND $7,966,118.00
- Revenue This Year
- ABVC $735.18
- RAND N/A
- Revenue Next Year
- ABVC N/A
- RAND N/A
- P/E Ratio
- ABVC N/A
- RAND N/A
- Revenue Growth
- ABVC 186.84
- RAND 1.16
- 52 Week Low
- ABVC $0.40
- RAND $13.82
- 52 Week High
- ABVC $5.48
- RAND $31.89
- Technical
- Relative Strength Index (RSI)
- ABVC 56.53
- RAND 32.85
- Support Level
- ABVC $2.90
- RAND $13.82
- Resistance Level
- ABVC $3.06
- RAND $17.05
- Average True Range (ATR)
- ABVC 0.28
- RAND 0.93
- MACD
- ABVC 0.00
- RAND -0.42
- Stochastic Oscillator
- ABVC 91.92
- RAND 26.73
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.
About RAND Rand Capital Corporation
Rand Capital Corp is a closed-end, externally managed, non-diversified investment company. The company's investment objective is to generate current income and, when possible, complement its current income with capital appreciation by focusing its debt and related equity investments in privately-held, lower middle market companies with committed and experienced managements in a broad variety of industries. It predominantly invests in higher-yielding debt instruments.